Table 2.
Antibiotic and antiseptic treatment of the patients expressed as number of patients treated
| Group A (n = 10) | Group B (n = 10) | |
|---|---|---|
| Bacterial culture available | 10 | 8 |
| Antibiotic treatment during therapy | 9 | 9 |
| Monotherapy | 4 | 7 |
| Amoxicillin/clavulanic acid | 3 | 3 |
| Cefazolin | 1 | 0 |
| Ceftiofur | 0 | 1 |
| Doxycycline | 0 | 3 |
| Multiple antibiotics | 5 | 2 |
| Amoxicillin/clavulanic acid + metronidazole | 3 | 1 |
| Amoxicillin/clavulanic acid + metronidazole + ceftiofur | 0 | 1 |
| Amoxicillin/clavulanic acid + metronidazole + marbofloxacin | 1 | 0 |
| Amoxicillin/clavulanic acid + metronidazole + gentamicin | 1 | 0 |
| Based on susceptibility testing | 9 | 8 |
| Adjusted during treatment | 6 | 4 |
| Marbofloxacin | 5 | 2 |
| Doxycycline | 1 | 2 |
| Discontinued during treatment | 2 | 0 |
| Antiseptic treatment during therapy | 10 | 10 |
| Polyhexanide | 10 | 10 |
| Acetic acid | 3 | 0 |